Financial reports
10-K
2023 FY
Annual report
1 Apr 24
ARS
2022 FY
Annual report to shareholders
14 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
21 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
5 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K
2021 FY
Annual report
29 Mar 22
Current reports
8-K
Synaptogenix Announces Reverse Stock Split to Maintain Nasdaq Listing
4 Apr 24
8-K
Departure of Directors or Certain Officers
21 Dec 23
8-K
Entry into a Material Definitive Agreement
6 Nov 23
8-K
Amendments to Articles of Incorporation or Bylaws
22 Sep 23
8-K
Study will evaluate drug’s potential neuro-restorative mechanism(s) of action for improving synaptic health and cognitive function in MS patients
19 Jul 23
8-K
Departure of Directors or Certain Officers
22 Jun 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
28 Apr 23
8-K
Submission of Matters to a Vote of Security Holders
14 Apr 23
8-K
Results of Operations and Financial Condition
7 Mar 23
8-K
Submission of Matters to a Vote of Security Holders
17 Feb 23
Registration and prospectus
424B3
Prospectus supplement
28 Dec 22
S-3
Shelf registration
16 Dec 22
S-8
Registration of securities for employees
22 Nov 22
S-3
Shelf registration
15 Apr 22
S-8
Registration of securities for employees
13 Aug 21
424B3
Prospectus supplement
7 Jul 21
S-1/A
IPO registration (amended)
2 Jul 21
D
$12.48M in equity / options, sold $12.48M, 14 investors
29 Jun 21
S-1
IPO registration
24 Jun 21
8-A12B
Registration of securities on exchange
4 Jun 21
Proxies
DEF 14A
Definitive proxy
13 Nov 23
PRE 14A
Preliminary proxy
3 Nov 23
DEF 14A
Definitive proxy
27 Mar 23
PRE 14A
Preliminary proxy
20 Mar 23
DEF 14A
Definitive proxy
9 Jan 23
PRE 14A
Preliminary proxy
28 Dec 22
DEFA14A
Additional proxy soliciting materials
25 Aug 22
DEF 14A
Definitive proxy
25 Aug 22
DEF 14A
Definitive proxy
12 Mar 21
PRE 14A
Preliminary proxy
1 Mar 21
Other
EFFECT
Notice of effectiveness
28 Dec 22
CORRESP
Correspondence with SEC
22 Dec 22
UPLOAD
Letter from SEC
22 Dec 22
EFFECT
Notice of effectiveness
28 Apr 22
CORRESP
Correspondence with SEC
25 Apr 22
UPLOAD
Letter from SEC
21 Apr 22
EFFECT
Notice of effectiveness
7 Jul 21
CORRESP
Correspondence with SEC
2 Jul 21
UPLOAD
Letter from SEC
1 Jul 21
CERT
Certification of approval for exchange listing
7 Jun 21
Ownership
4
William S. Singer
10 Apr 24
4
Joshua Silverman
10 Apr 24
4
JONATHAN SCHECHTER
10 Apr 24
4
Bruce Bernstein
10 Apr 24
SC 13G/A
INTRACOASTAL CAPITAL, LLC
6 Feb 24
4
JONATHAN SCHECHTER
31 Mar 23
4
William S. Singer
31 Mar 23
4
Bruce Bernstein
31 Mar 23
4
Joshua Silverman
31 Mar 23
SC 13G/A
INTRACOASTAL CAPITAL, LLC
8 Feb 23